TOP TEN perturbations for 38903_at (Homo sapiens)
Organism: Homo sapiens
Gene: 38903_at
Selected probe(set): 206156_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 38903_at (206156_at) across 6674 perturbations tested by GENEVESTIGATOR:
esophageal adenocarcinoma study 1 / normal esophageal epithelium sample
Relative Expression (log2-ratio):-3.8827362Number of Samples:20 / 18
Experimental | esophageal adenocarcinoma study 1 |
Esophageal adenocarcinoma (EAC) samples of affected epithelium recovered by laser capture microdissection technique. | |
Control | normal esophageal epithelium sample |
Histologically normal esophageal squamous cell epithelium biopsy samples from patients that were investigated for esophageal pain, but diagnosed as healthy. |
esophagus cancer study 1 (PDX; squamous cell carcinoma, NOS; primary) / esophagus cancer study 1 (PDX; adenocarcinoma, NOS; primary)
Relative Expression (log2-ratio):3.5832596Number of Samples:3 / 8
Experimental | esophagus cancer study 1 (PDX; squamous cell carcinoma, NOS; primary) |
Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary squamous cell carcinoma, NOS of the oesophagus (subcutaneously implanted). | |
Control | esophagus cancer study 1 (PDX; adenocarcinoma, NOS; primary) |
Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary adenocarcinoma, NOS of the oesophagus (subcutaneously implanted). |
melanoma study 34 (metastatic) / melanoma study 34 (in situ)
Relative Expression (log2-ratio):-3.4624424Number of Samples:40 / 2
Experimental | melanoma study 34 (metastatic) |
Metastatic tumor tissue sample obtained from the patients with metastatic malignant melanoma of the skin. Metastatic samples composed of 22 macroscopic lymph node metastases, 16 subcutaneous metastases and 2 solid organ metastases (adrenal and brain). | |
Control | melanoma study 34 (in situ) |
Tumor tissue from the skin of patients with melanoma in situ. |
Barrett's esophagus study 3 / normal esophageal epithelium sample
Relative Expression (log2-ratio):-3.3384447Number of Samples:17 / 18
Experimental | Barrett's esophagus study 3 |
Esophageal epithelium samples from areas with Barrett's esophagus metaplasia which were recovered by laser capture microdissection. | |
Control | normal esophageal epithelium sample |
Histologically normal esophageal squamous cell epithelium biopsy samples from patients that were investigated for esophageal pain, but diagnosed as healthy. |
Merkel cell carcinoma study 3 (primary) / skin squamous cell carcinoma study 6
Relative Expression (log2-ratio):-3.2240982Number of Samples:19 / 4
Experimental | Merkel cell carcinoma study 3 (primary) |
Primary tumor tissue from the skin of patients with Merkel cell carcinoma. | |
Control | skin squamous cell carcinoma study 6 |
Primary tumor tissue from the skin of patients with squamous cell carcinoma (SCC). |
melanoma study 34 (metastatic) / normal skin tissue
Relative Expression (log2-ratio):-3.166685Number of Samples:40 / 4
Experimental | melanoma study 34 (metastatic) |
Metastatic tumor tissue sample obtained from the patients with metastatic malignant melanoma of the skin. Metastatic samples composed of 22 macroscopic lymph node metastases, 16 subcutaneous metastases and 2 solid organ metastases (adrenal and brain). | |
Control | normal skin tissue |
Normal skin tissue. |
Merkel cell carcinoma study 3 (primary) / normal skin tissue
Relative Expression (log2-ratio):-3.0688372Number of Samples:19 / 64
Experimental | Merkel cell carcinoma study 3 (primary) |
Primary tumor tissue from the skin of patients with Merkel cell carcinoma. | |
Control | normal skin tissue |
Normal skin samples from healthy donors. |
Merkel cell carcinoma study 3 (metastatic) / normal skin tissue
Relative Expression (log2-ratio):-3.0341473Number of Samples:11 / 64
Experimental | Merkel cell carcinoma study 3 (metastatic) |
Metastatic tumor tissue from different metastatic sites (skin, lymph node, parotid gland) of patients with Merkel cell carcinoma of the skin. | |
Control | normal skin tissue |
Normal skin samples from healthy donors. |
expO cervical cancer study 1 (squamous cell carcinoma, keratinizing type, NOS; primary) / expO cervical cancer study 1 (adenosquamous carcinoma; primary)
Relative Expression (log2-ratio):2.925766Number of Samples:3 / 2
Experimental | expO cervical cancer study 1 (squamous cell carcinoma, keratinizing type, NOS; primary) |
Primary tumor tissue samples obtained from the cervix uteri of patients with squamous cell carcinoma, keratinizing type (NOS). | |
Control | expO cervical cancer study 1 (adenosquamous carcinoma; primary) |
Primary tumor tissue samples obtained from the cervix uteri of patients with adenosquamous carcinoma. |
expO cervical cancer study 1 (squamous cell carcinoma, keratinizing type, NOS; primary) / expO cervical cancer study 1 (adenocarcinoma, NOS; primary)
Relative Expression (log2-ratio):2.753747Number of Samples:3 / 6
Experimental | expO cervical cancer study 1 (squamous cell carcinoma, keratinizing type, NOS; primary) |
Primary tumor tissue samples obtained from the cervix uteri of patients with squamous cell carcinoma, keratinizing type (NOS). | |
Control | expO cervical cancer study 1 (adenocarcinoma, NOS; primary) |
Primary tumor tissue samples obtained from the cervix uteri of patients with adenocarcinoma (NOS). |